The Future of Affordable Drugs

Imprimis Pharmaceuticals is striving to provide affordable, safe generic drugs in the US, starting with a cheaper alternative to Daraprim for treating infections in HIV-positive individuals. The manufacturing rights to Daraprim were purchased by Turing Pharmaceuticals in September, with prices rising from $13 to $750 overnight, provoking outrage from politicians and HIV/AIDS charities alike. The alternative drug will cost $1 per pill, with discounts for those who can’t afford it, and contains a very similar formulation to Daraprim, using the same generic compound as the active ingredient, pyrimethamine. This generic drug is not approved by the Food and Drug Administration (FDA) in the US, but may be sold with a doctor’s prescription there.

Leave a Reply

Your email address will not be published. Required fields are marked *